JP2023517532A5 - - Google Patents
Info
- Publication number
- JP2023517532A5 JP2023517532A5 JP2022552858A JP2022552858A JP2023517532A5 JP 2023517532 A5 JP2023517532 A5 JP 2023517532A5 JP 2022552858 A JP2022552858 A JP 2022552858A JP 2022552858 A JP2022552858 A JP 2022552858A JP 2023517532 A5 JP2023517532 A5 JP 2023517532A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- epinephrine
- type
- particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062989913P | 2020-03-16 | 2020-03-16 | |
| US62/989,913 | 2020-03-16 | ||
| US17/135,528 US11400045B2 (en) | 2020-03-16 | 2020-12-28 | Treatment with powdered intranasal epinephrine |
| US17/135,528 | 2020-12-28 | ||
| PCT/IL2021/050288 WO2021186437A1 (en) | 2020-03-16 | 2021-03-16 | Treatment with powdered intranasal epinephrine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023517532A JP2023517532A (ja) | 2023-04-26 |
| JP2023517532A5 true JP2023517532A5 (https=) | 2024-03-27 |
Family
ID=77664091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022552858A Pending JP2023517532A (ja) | 2020-03-16 | 2021-03-16 | 粉末化された鼻腔内エピネフリンによる治療 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11400045B2 (https=) |
| EP (1) | EP4121005A1 (https=) |
| JP (1) | JP2023517532A (https=) |
| KR (1) | KR20220154709A (https=) |
| CN (1) | CN115279340A (https=) |
| AR (1) | AR121593A1 (https=) |
| AU (1) | AU2021239084A1 (https=) |
| BR (1) | BR112022018440A2 (https=) |
| CA (1) | CA3175130A1 (https=) |
| IL (1) | IL296268A (https=) |
| MX (1) | MX2022011464A (https=) |
| TW (1) | TW202200119A (https=) |
| WO (1) | WO2021186437A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11400045B2 (en) * | 2020-03-16 | 2022-08-02 | Nasus Pharma Ltd. | Treatment with powdered intranasal epinephrine |
| PT3962455T (pt) | 2020-05-18 | 2022-10-13 | Orexo Ab | Nova composição farmacêutica para entrega de fármacos |
| US12414916B2 (en) | 2021-06-10 | 2025-09-16 | Belhaven BioPharma Inc. | Dry powder formulations of epinephrine and associated methods |
| AR127780A1 (es) | 2021-11-25 | 2024-02-28 | Orexo Ab | Nueva composición farmacéutica que comprende adrenalina |
| GB202117016D0 (en) | 2021-11-25 | 2022-01-12 | Orexo Ab | New pharmaceutical device |
| US12029709B2 (en) | 2022-08-11 | 2024-07-09 | De Motu Cordis Pty Ltd | Inhalable epinephrine formulation |
| KR20250048076A (ko) * | 2022-08-11 | 2025-04-07 | 드 모투 코르디스 피티와이 엘티디 | 흡입형 에피네프린 제형 |
| TW202502309A (zh) * | 2023-05-31 | 2025-01-16 | 瑞典商奥瑞克索股份公司 | 包含腎上腺素激導性受體調節劑的噴霧乾燥之組合物 |
| US20260108686A1 (en) | 2024-10-21 | 2026-04-23 | Belhaven BioPharma Inc. | Compositions, devices, and methods for intranasal delivery of dry powder epinephrine |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8337817B2 (en) * | 2006-12-26 | 2012-12-25 | Shin Nippon Biomedical Laboratories, Ltd. | Preparation for transnasal application |
| CN102166219B (zh) * | 2010-05-25 | 2013-04-17 | 杭州天龙药业有限公司 | 一种鼻腔给药制剂及其应用 |
| US9789071B2 (en) | 2012-06-27 | 2017-10-17 | G2B Pharma, Inc. | Intranasal formulation of epinephrine for the treatment of anaphylaxis |
| MX2016002705A (es) | 2013-09-03 | 2016-09-06 | G2B Pharma Inc | Formulacion intranasal para el tratamiento por reanimacion cardiopulmonar (rcp), mantenimiento cardiaco vital (cls), de anafilaxia y/o reacciones anafilactoides. |
| US20200069582A1 (en) | 2014-07-03 | 2020-03-05 | Darren Rubin | Inhalable hemodynamic agents and methods of using the same |
| CN107205938A (zh) * | 2014-12-18 | 2017-09-26 | 温德加普医疗股份有限公司 | 用于溶解或增溶治疗剂的方法和组合物 |
| US11844859B2 (en) * | 2017-08-20 | 2023-12-19 | Nasus Pharma Ltd. | Dry powder compositions for intranasal delivery |
| EP3668490A4 (en) * | 2017-08-20 | 2021-06-09 | Formulex Pharma Innovations Ltd. | Dry powder compositions for intranasal delivery |
| GB2600026B (en) * | 2018-02-06 | 2022-10-12 | Aegis Therapeutics Llc | Intranasal epinephrine formulations and methods for the treatment of disease |
| US11400045B2 (en) * | 2020-03-16 | 2022-08-02 | Nasus Pharma Ltd. | Treatment with powdered intranasal epinephrine |
-
2020
- 2020-12-28 US US17/135,528 patent/US11400045B2/en active Active
-
2021
- 2021-03-16 MX MX2022011464A patent/MX2022011464A/es unknown
- 2021-03-16 JP JP2022552858A patent/JP2023517532A/ja active Pending
- 2021-03-16 EP EP21714436.9A patent/EP4121005A1/en active Pending
- 2021-03-16 CA CA3175130A patent/CA3175130A1/en active Pending
- 2021-03-16 WO PCT/IL2021/050288 patent/WO2021186437A1/en not_active Ceased
- 2021-03-16 BR BR112022018440A patent/BR112022018440A2/pt unknown
- 2021-03-16 AR ARP210100664A patent/AR121593A1/es unknown
- 2021-03-16 KR KR1020227033697A patent/KR20220154709A/ko not_active Withdrawn
- 2021-03-16 CN CN202180020993.7A patent/CN115279340A/zh active Pending
- 2021-03-16 AU AU2021239084A patent/AU2021239084A1/en active Pending
- 2021-03-16 IL IL296268A patent/IL296268A/en unknown
- 2021-03-16 US US17/911,523 patent/US20230105615A1/en active Pending
- 2021-03-16 TW TW110109439A patent/TW202200119A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023517532A5 (https=) | ||
| TWI583384B (zh) | 包含４－胺基－５－氟－３－［６－（４－甲基哌嗪－１－基）－１ｈ－苯并咪唑－２－基］－１ｈ－喹啉－２－酮乳酸鹽單水合物之醫藥組合物 | |
| US20130095180A1 (en) | Time-delayed sustained release pharmaceutical composition comprising dapoxetine for oral administration | |
| JP2007533686A5 (https=) | ||
| JP5911969B2 (ja) | 心臓血管障害の治療方法 | |
| JP2007314578A (ja) | 経口投与後のトリメタジジンの持続性放出を可能とするマトリックス錠 | |
| JP2005512995A5 (https=) | ||
| PT2124556E (pt) | Composições farmacêuticas | |
| JP2006527195A (ja) | トリプタンおよびｎｓａｉｄを含む組成物 | |
| ES2324769T3 (es) | Comprimido que comprende cetrizina y pseudoefedrina. | |
| CN1972730A (zh) | 格隆溴铵用于治疗儿童哮喘 | |
| JP5941258B2 (ja) | 他の薬剤と組合せた（ｒ，ｒ）−ホルモテロール | |
| JP2025165977A (ja) | 二層医薬錠剤製剤 | |
| JP2005515991A (ja) | ５ｈｔ１レセプターアゴニストを含む医薬組成物 | |
| WO2005094832A1 (en) | Compositions comprising meloxicam | |
| TW202237145A (zh) | 莫奈皮拉韋的醫藥組成物 | |
| JP2016537364A5 (https=) | ||
| JP5713421B1 (ja) | 口腔内崩壊錠 | |
| ES2241777T3 (es) | Composiciones farmaceuticas que contienen terbinafina. | |
| JP2009535336A (ja) | 片頭痛治療用の固定組合せ剤形 | |
| KR20210137484A (ko) | 캡시드 조립 조절제 고체 제형 | |
| WO2008068778A2 (en) | Extended release pharmaceutical composition of pramipexole | |
| JP2513656B2 (ja) | 血小板凝集阻止作用を有する併用組合せ製剤 | |
| PT1646373E (pt) | Composição farmacêutica orodispersível de um composto antitrombótico | |
| JP4500051B2 (ja) | ピリベジルの口内分散性薬剤組成物 |